The Daily: 'A Flood of New, Deadlier Drugs' Review

The Daily, the flagship daily news podcast from The New York Times, has become essential listening for anyone trying to understand what's actually happening in the world. In this week's episode, "A Flood of New, Deadlier Drugs," host Natalie Kitroleth and investigative reporter Osam Ahmed examine a public health crisis that's quietly intensifying while America remains focused on the fentanyl epidemic. The episode explores how new synthetic drugs—designed in labs rather than grown from plants—are faster-acting, far more addictive, and dramatically deadlier than previous generations of opioids. Ahmed's reporting from Mexico and beyond reveals why this is happening: synthetic drug manufacturing has democratized, making it cheaper and easier to produce substances, trivial to modify them to evade legal restrictions, and vastly more profitable than traditional drug trafficking. Kitroleth's interviewing is sharp—she consistently pushes Ahmed to ground his points in specifics rather than letting him generalize. We rated this episode 7.6/10 because it's excellent journalism on a critical topic, though it stops short of The Daily's deepest investigative work. The episode runs 28.3 minutes with 2 ads totaling 1.3 minutes, and you can skip The Daily ads automatically while you listen.

What Makes The Daily 'A Flood of New, Deadlier Drugs' Work

Ahmed's reporting is the episode's foundation. He's spent time embedded in Mexico's drug-manufacturing regions, and he brings that fieldwork perspective to conversations about scale: 1,450 new psychoactive substances discovered in the last decade, a number that's tripled in ten years. That's not a statistic—that's a rate of change that suggests a systemic problem spiraling faster than policy can track.

The episode's architecture is smart. Kitroleth begins by acknowledging the fentanyl crisis Americans know about, then Ahmed walks through why fentanyl might be less dangerous than what's coming next. This creates narrative tension that makes you lean in: if fentanyl is already a catastrophe, what could be worse? The answer—drugs that are easier to make, cheaper to smuggle, quicker to act, and harder to treat—is genuinely unsettling.

What sets this episode apart is Ahmed's insistence on the mechanisms behind the crisis, not just the body count. He explains why synthetic drugs are fundamentally different from plant-based drugs: you can manufacture them anywhere, in spaces as small as a kitchen. You can modify their molecular structure continuously, creating new substances faster than regulators can ban them. Each modification can increase potency or reduce treatment effectiveness. This isn't a supply problem with a law-enforcement solution—it's a chemistry problem, which makes it exponentially harder to solve.

Kitroleth's interviewing keeps Ahmed grounded. Instead of letting him speak in abstractions about "the global drug trade," she asks him where, exactly, he saw a fentanyl lab. (A kitchen in Sinaloa.) What surprised him most? (The ease of scaling.) Who's involved? (Not just traffickers—also chemists, entrepreneurs, people optimizing for profit.) These questions transform the episode from a policy conversation into a narrative about real people making real choices with terrible consequences.

The episode includes this powerful early line:

"Just as America is beginning to wrap its arms around the fentanyl crisis, a new kind of drug epidemic is emerging."

That works because it's not sensationalism—it's what the data actually supports. Ahmed's reporting shows that the drug market is evolving faster than public understanding of it, and the policy infrastructure built to fight fentanyl might be obsolete before it's fully implemented.

The Ad Load on The Daily: 2 Ads, 1.3 Minutes

This episode contains 2 ads totaling 1.3 minutes (4.6% of the 28.3-minute runtime, with NYT as a detected sponsor), and you can skip The Daily ads automatically while you listen.

The Daily Review: Is 'A Flood of New, Deadlier Drugs' Worth Listening?

7.6/10. This is excellent journalism on a critical, urgent topic with thorough reporting and sharp interviewing—the only reason it doesn't score higher is that it maps the problem without meaningfully exploring solutions.

FAQ: The Daily 'A Flood of New, Deadlier Drugs' Review

What is 'A Flood of New, Deadlier Drugs' about?

The episode investigates how new synthetic drugs are creating a public health crisis worse than fentanyl. Reporter Osam Ahmed and host Natalie Kitroleth explain why lab-made drugs are easier to manufacture, easier to modify for legal workarounds, and dramatically more lethal than traditional opioids, and what this shift means for drug policy and treatment.

How many ads are in the episode?

The episode runs 28.3 minutes with 2 ads totaling 1.3 minutes of ad time (4.6% of the runtime). You can automatically skip them while you listen using PodSkip, which works on The Daily and every other podcast app.

Where can I listen to The Daily?

You can find The Daily on Apple Podcasts and all major podcast platforms. Recent episodes worth checking out include "Sites Unseen: What's Revealed by Traveling With the Blind" (7.8/10) and "Trump's National Support Is Cratering" (7.9/10), both of which have the same production quality you'll find here.

▶ See all The Daily episodes on PodSkip →